iZafe Group's Quarterly Report Q4, October-December 2025

STOCKHOLM, SE / ACCESS Newswire / February 16, 2026 / iZafe Group AB (publ.)(STO:IZAFE-B) today, February 16, publishes its report for the fourth quarter.

Financial Performance in Summary

• The Group's total net sales for the quarter amounted to 2,435 TSEK (2,345) and consisted entirely of recurring license revenues, with no hardware sales during the period. This is in contrast to the corresponding quarter of the previous year, when revenues were largely derived from hardware sales. The development demonstrates that iZafe Group has now established a business model focused on recurring revenues. During the quarter, the Group also began consolidating revenues from the Dutch operations, contributing to net sales and strengthening the recurring revenue base. At the beginning of 2026, the Group's annual recurring revenue (ARR) amounted to approximately 10 MSEK, in line with the Company's previously communicated target.

• Operating result (EBIT) for the quarter amounted to -5,714 TSEK (-5,679).

• Earnings before depreciation and amortization (EBITDA) for the quarter amounted to -3,888 TSEK (-4,174). The result represents an improvement compared to the previous year but was during the quarter impacted by the consolidation of the Dutch operations as well as increased investments to support the positive business development and continued growth.

• Result after financial items for the quarter amounted to -4,971 TSEK (-5,908).

• Cash flow from operating activities for the quarter amounted to -2,940 TSEK (-178).

• Earnings per share for the quarter before/after dilution amounted to -0.01 SEK (-0.02).

• Equity per share at the end of the period amounted to 0.03 SEK (0.04).

• The equity ratio at the end of the period was 32.8% (40.1%).

Significant events during the quarter

• iZafe Group AB (publ.) has entered into a distribution agreement with Skand ehf regarding the launch and sale of the Dosell medication dispensing device in Iceland. The agreement represents a step in the Company's Nordic expansion and entails that Dosell is established in an additional European market. As part of the agreement, Skand ehf has placed an initial order of 300 Dosell units with planned delivery during 2026, which, once fully activated, is expected to generate annual recurring revenue (ARR) of approximately 2-3 MSEK.